Skip to main content
Mahamaya Lifesciences IPO
1.69xsubscribed

Mahamaya Lifesciences IPO

listed
₹2.59LMin. investment

Mahamaya Lifesciences Limited IPO Details

Price range₹108 – ₹114
IPO type
SME
Lot size1200 shares
Issue size₹70Cr
Red Herring Prospectus
Read
Market cap
₹266.82CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹264.15CrLower than sector avg
Growth rate3Y CAGR
38.82%

Mahamaya Lifesciences IPO Subscription Status

Date
QIB
NII
Retail
Total
11-Nov-25
0.26 times (X)
0.0 times (X)
0.07 times (X)
0.11 times (X)
12-Nov-25
0.26X
0.27X
0.2X
0.42X
13-Nov-25
0.86X
2.82X
1.01X
1.69X

As on 11-Nov-25, 5:30 PM

Mahamaya Lifesciences IPO Timeline

  1. Pre-apply
    10 Nov 2025
  2. Bid start
    11 Nov 2025
  3. Bid end
    13 Nov 2025
  4. Allotment
    14 Nov 2025
  5. Release of funds
    17 Nov 2025
  6. Demat transfer
    17 Nov 2025
  7. Listing
    18 Nov 2025

About Mahamaya Lifesciences Limited

Incorporated in 2002, Mahamaya Lifesciences is engaged in the manufacturing of pesticide and bulk formulations catering to Indian agrochemical firms as well as multinational corporations (MNCs). The company operates a manufacturing facility located at Dahej, Gujarat. As of June 30, 2025, it offers a diverse product range including 136 insecticide products, 71 fungicide products, 58 herbicide products, 9 bio-stimulants, 3 biopesticides and 1 Biofertilizer. In FY25 domestic sales accounted for 95.30% of revenues at ₹251.73 crore and exports 4.70% at ₹12.42 crore. Capacity utilisation for solids stood at 113.37%, while that for liquids was 63.77% as of June, 2025. Its dealer network consists of 310+ dealers, spread across 8 states in India, and internationally, the company exports to countries such as Egypt, Turkey and UAE.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Mahamaya Lifesciences Limited IPO

Capital expenditure
45.77%
₹29.42 crore will be used to establish a new manufacturing plant.
Working capital
28.00%
The company will utilise ₹18 crore for funding working capital requirement
General corporate purposes
16.50%
Part of the IPO proceeds will be used for general corporate purposes
Purchase of equipment
5.83%
The company will utilise ₹3.75 crore for purchasing equipment for the existing formulation plant.
Construction of warehouse building
3.94%
The company will utilise ₹2.53 crore to construct warehouse building and purchase of machinery.

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹264.15Cr38.82%₹12.94Cr₹266.82Cr15.001.08
This sector (avg.)₹2,166.44Cr---₹120.15Cr₹7,758.76Cr32.380.50
₹46,637Cr---₹820Cr₹59,422.93Cr28.320.77
₹7,977.8Cr---₹1,660.2Cr₹48,475.25Cr32.060.02
₹3,148.52Cr---₹506.44Cr₹20,447.5Cr38.480.02

*Revenue for financial year 2024-25. Lower P/E and D/E ratios are generally preferred.

Mahamaya Lifesciences IPO Contact Details

Company NameMahamaya Lifesciences Limited

How to apply for Mahamaya Lifesciences IPO?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Mahamaya Lifesciences Limited IPO FAQs